Skip to main content

and
  1. Article

    Open Access

    Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

    Penis cancer is rare and clinical trial evidence on which to base treatment decisions is limited. Case reports suggest that the combination of docetaxel, cisplatin and 5-flurouracil (TPF) is highly active in t...

    S Nicholson, E Hall, S J Harland, J D Chester, L Pickering in British Journal of Cancer (2013)

  2. Article

    Open Access

    Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

    Adjuvant BEP (bleomycin, etoposide, cisplatin) is effective treatment for high-risk clinical stage I (HRCS1) non-seminomatous germ cell tumours (NSGCT), but the known toxicities of etoposide, and the expansion...

    D P Dearnaley, S D Fossa, S B Kaye, M H Cullen, S J Harland in British Journal of Cancer (2005)

  3. Article

    Open Access

    Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer

    The aim of this study was to examine the efficacy and toxicity of the epirubicin, carboplatin and 5-fluorouracil (ECarboF) regime in patients aged 70 or less with metastatic prostate cancer resistant to LHRH a...

    A J Birtle, J C Newby, S J Harland in British Journal of Cancer (2004)

  4. Article

    Open Access

    Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

    High-dose regimes containing etoposide, carboplatin and an oxazaphospharine can salvage 30–40% of patients with relapsed or refractory male germ cell tumours (GCTs). The additional benefit of paclitaxel in suc...

    I A McNeish, E J Kanfer, R Haynes, C Giles, S J Harland in British Journal of Cancer (2004)

  5. No Access

    Article

    The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer

    Samples of metastatic prostate cancer to bone are difficult to obtain. The aim of this study was to compare the results of bone marrow aspirate and trephine biopsy for obtaining metastatic hormone-refractory p...

    R S D Brown, A Dogan, P J Ell, H A Payne in Prostate Cancer and Prostatic Diseases (2002)

  6. Article

    Open Access

    Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis

    In order to ascertain the incidence and prognosis of cisplatin-induced neurotoxicity in testis cancer patients undergoing combination chemotherapy, 29 patients with metastatic disease were studied prospectivel...

    M von Schlippe, C J Fowler, S J Harland in British Journal of Cancer (2001)

  7. Article

    Open Access

    A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

    The UK Medical Research Council conducted this trial of carboplatin chemotherapy in advanced seminoma to compare single agent carboplatin with a standard combination of etoposide with cisplatin. The use of sin...

    A Horwich, R T D Oliver, P M Wilkinson, G M Mead, S J Harland in British Journal of Cancer (2000)

  8. No Access

    Article

    Polymorphically acetylated aminoglutethimide in humans

    The urinary excretion during 24 h of aminoglutethimide (AG) its major metabolite (N-acetylAG) and two minor metabolites (N-formylAG and nitroG) were measured in 10 volunteers given AG who had been typed for ac...

    R C Coombes, A B Foster, S J Harland, M Jarman, E C Nice in British Journal of Cancer (1982)